Skip to main content

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1164508 BOSTON, MA

Position in TAK

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$57,714,079
-$30,881,505 QoQ
Shares Held
3,116,311
-45.2% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 63.79366500968613.ToString("F0")% Shared 0.ToString("F0")% None 36.20633499031386.ToString("F0")%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $805,226,112 across 23 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 TAK
Takeda Pharmaceutical Co Ltd
This page
3,116,311 $57,714,079

All Filings in TAK

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $57,714,079 3,116,311
2025-12-31 $88,595,584 5,682,847
2025-09-30 $41,413,309 2,828,778
2025-06-30 $18,840,947 1,218,690
2025-03-31 $20,824,780 1,400,456
2024-12-31 $55,824,778 4,216,373
2024-09-30 $65,915,274 4,635,392
2024-06-30 $29,962,764 2,315,515
2024-03-31 $18,958,836 1,364,927
2023-12-31 $27,230,313 1,908,221
2023-09-30 $38,271,387 2,473,910
2023-06-30 $36,670,203 2,334,195
2023-03-31 $17,423,892 1,057,275
2022-12-31 $60,907,017 3,904,296
2022-09-30 $18,665,360 1,439,118
2022-06-30 $14,504,527 1,033,086
2022-03-31 $2,315,730 161,713
2021-06-30 $1,475,991 87,700
2021-03-31 $4,768,252 261,131
2020-12-31 $4,207,439 231,178
2020-09-30 $8,023,450 449,745
2020-06-30 $9,584,983 534,578
2020-03-31 $6,299,715 415,001